1
Pharmacokinetic Study of Melphalan in Pediatric Hematopoietic Stem Cell Transplantation
Condition(s):Hematopoietic Stem Cell TransplantationLast Updated:February 6, 2023Recruiting
Melphalan: 960 Clinical Trials, Page 1 of 96
Hide Studies Not Open or Pending
2
A Pharmacokinetic Study of Melphalan in Children
Condition(s):Hematopoietic Stem Cell TransplantationLast Updated:August 30, 2021Completed
3
Topotecan and Melphalan for Retinoblastoma
Condition(s):Retinoblastoma; Chemotherapy EffectLast Updated:March 16, 2021Recruiting
4
Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis
Condition(s):Non-cystic Fibrosis BronchiectasisLast Updated:February 20, 2020Unknown status
5
Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients
Condition(s):Amyloidosis; SystemicLast Updated:July 6, 2022Terminated
6
Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma
Condition(s):Hepatocellular Carcinoma; Intrahepatic CholangiocarcinomaLast Updated:October 17, 2022Terminated
7
Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment
Condition(s):Metastatic MelanomaLast Updated:February 27, 2019Unknown status
8
Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Condition(s):Hematologic Malignancies; Nonmalignant Diseases; Immunodeficiencies; Hemoglobinopathies; Genetic Inborn Errors of Metabolism; Fanconi’s Anemia; Thalassemia; Sickle Cell DiseaseLast Updated:October 4, 2021Completed
9
Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia
Condition(s):COVID-19; Viral PneumoniaLast Updated:May 12, 2020Unknown status
10
PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation
Condition(s):Multiple MyelomaLast Updated:December 17, 2019Completed